BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 34507653)

  • 1. Explore the potential molecular mechanism of polycystic ovarian syndrome by protein-protein interaction network analysis.
    Chen Q; Zheng B; Du S; Lin Y
    Taiwan J Obstet Gynecol; 2021 Sep; 60(5):807-815. PubMed ID: 34507653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of labor related gene subtype classification on heterogeneity of polycystic ovary syndrome.
    Zhou J; Jiang Z; Fu L; Qu F; Dai M; Xie N; Zhang S; Wang F
    PLoS One; 2023; 18(3):e0282292. PubMed ID: 36857354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of key pathways and genes in polycystic ovary syndrome via integrated bioinformatics analysis and prediction of small therapeutic molecules.
    Devarbhavi P; Telang L; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
    Reprod Biol Endocrinol; 2021 Feb; 19(1):31. PubMed ID: 33622336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome: Identification of novel and hub biomarkers in the autophagy-associated mRNA-miRNA-lncRNA network.
    Huang J; Huang B; Kong Y; Yang Y; Tian C; Chen L; Liao Y; Ma L
    Front Endocrinol (Lausanne); 2022; 13():1032064. PubMed ID: 36523600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the key pathways and genes related to polycystic ovary syndrome using bioinformatics analysis.
    Bi X; Zhai Z; Wang S
    Gen Physiol Biophys; 2019 May; 38(3):205-214. PubMed ID: 31184307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathway and network-based analysis of genome-wide association studies and RT-PCR validation in polycystic ovary syndrome.
    Shen H; Liang Z; Zheng S; Li X
    Int J Mol Med; 2017 Nov; 40(5):1385-1396. PubMed ID: 28949383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated bioinformatics analysis and screening of hub genes in polycystic ovary syndrome.
    Qiao G; Xing J; Luo X; Zhang C; Yi J
    Endocrine; 2022 Dec; 78(3):615-627. PubMed ID: 36068422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of polycystic ovary syndrome potential drug targets based on pathobiological similarity in the protein-protein interaction network.
    Huang H; He Y; Li W; Wei W; Li Y; Xie R; Guo S; Wang Y; Jiang J; Chen B; Lv J; Zhang N; Chen L; He W
    Oncotarget; 2016 Jun; 7(25):37906-37919. PubMed ID: 27191267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics identification of microRNAs involved in polycystic ovary syndrome based on microarray data.
    Hou Y; Wang Y; Xu S; Qi G; Wu X
    Mol Med Rep; 2019 Jul; 20(1):281-291. PubMed ID: 31115532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PCOSKB
    Sharma M; Barai RS; Kundu I; Bhaye S; Pokar K; Idicula-Thomas S
    Sci Rep; 2020 Sep; 10(1):14738. PubMed ID: 32895427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and validation of senescence-related genes in polycystic ovary syndrome.
    Jiang D; Xu Y; Yang L; Li P; Han X; Li Q; Yang Y; Chao L
    J Ovarian Res; 2024 Jan; 17(1):7. PubMed ID: 38184636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics-based analysis of potential therapeutic target genes for polycystic ovary syndrome.
    Liu Y; Yu J; Li J; Li W; Ma H
    Cell Mol Biol (Noisy-le-grand); 2024 Apr; 70(4):169-175. PubMed ID: 38678611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray analysis of obese women with polycystic ovary syndrome for key gene screening, key pathway identification and drug prediction.
    Wei L; Xin C; Wang W; Hao C
    Gene; 2018 Jun; 661():85-94. PubMed ID: 29601948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of long non-coding RNA and messenger RNA profiles in follicular fluid from mature and immature ovarian follicles of healthy women and women with polycystic ovary syndrome.
    Jiao J; Shi B; Wang T; Fang Y; Cao T; Zhou Y; Wang X; Li D
    Hum Reprod; 2018 Sep; 33(9):1735-1748. PubMed ID: 30052945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of the similarly expressed genes in patients with polycystic ovary syndrome and transsexuals.
    Dong R; Gao S; Shan MJ
    Medicine (Baltimore); 2021 Sep; 100(35):e26990. PubMed ID: 34477128
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing new drug candidates and identifying crucial molecules underlying PCOS Pathogenesis Based On Bioinformatics Analysis.
    Dehghan Z; Mohammadi-Yeganeh S; Sameni M; Mirmotalebisohi SA; Zali H; Salehi M
    Daru; 2021 Dec; 29(2):353-366. PubMed ID: 34480296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
    Liu L; He D; Wang Y; Sheng M
    Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein-Protein Interaction Network Analysis Reveals Several Diseases Highly Associated with Polycystic Ovarian Syndrome.
    Ramly B; Afiqah-Aleng N; Mohamed-Hussein ZA
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31216618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis.
    Zou J; Li Y; Liao N; Liu J; Zhang Q; Luo M; Xiao J; Chen Y; Wang M; Chen K; Zeng J; Mo Z
    J Ovarian Res; 2022 Feb; 15(1):30. PubMed ID: 35227296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of shared gene signatures and biological mechanisms between polycystic ovary syndrome and asthma: Based on weighted gene coexpression network analysis.
    Bai L; Gao X; Guo Y; Gong J; Li Y; Huang H; Liu X
    Int J Gynaecol Obstet; 2024 Apr; 165(1):155-168. PubMed ID: 38055328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.